Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / conflicts-clearance-memo.docx
conflicts-clearance-memo.docx
Parties
HARKNESS LLP
Penterra Pharmaceuticals Corp
Capitol Corp
Tidewater Registered Agents LLC
Northbridge Accounting Group LLP
Cole LLP
Elaine Sato Ridgeway Partners LLC
Driscoll Broadleaf Scientific Consulting LLC
Dates
February 13, 2024
February 12, 2024
February 13, 2019
Amounts
$87.3
Obligations
7(a)(1) of the New York Rules of Professional Conduct provides that a lawyer shall not represent a client if the representation will be directly adverse to another client, unless certain conditions permitting informed consent are satisfied
As a standard precautionary measure, all members of the proposed engagement team and any Firm personnel who become aware of this matter are reminded of the following obligations: (a) Each engagement team member must affirmatively confirm that he or she does not hold any personal investment in Penterra (Nasdaq: PPCA) or any related entity, including Veridian, any of its stockholders, or any other transaction counterparty; (b) No engagement team member or Firm personnel with knowledge of this matter may purchase, sell, or otherwise trade in securities of Penterra (Nasdaq: PPCA) during the pendency of the engagement, in accordance with the Firm's Insider Trading and Personal Investment Policy (revised September 2023); and (c) Any Firm personnel who subsequently acquires knowledge of a personal financial interest in any transaction party must promptly notify the Office of the General Counsel
All documents, communications, and work product related to this matter must be maintained in secure files and should not be discussed in public spaces or through unsecured communication channels